Q. Two members of our book group have early signs of cognitive impairment. We have become so close after 10 years of being ...
One particular metabolite, AMK, has shown great potential in improving memory and safeguarding against cognitive ...
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
A recent study led by researchers at the University of Southern California (USC) has uncovered a connection between mild ...
Mild cognitive impairment is linked to blood vessel dysfunction in the brain's temporal lobes -- the seat of memory -- according to a new study. The findings, seen in people with and without signs of ...